<?xml version="1.0" encoding="UTF-8"?>
<p>Besides the interest in the repurposed drugs included in the interim guidelines for COVID-19 treatment, a great interest was attracted globally by the new anti-SARS-CoV-2 agents. A considerable number of articles was dedicated to this subject (more than 10,000 articles found in PubMed database) and, in the next section, the most studied of these compounds in the actual context will be briefly discussed.</p>
